TY  - JOUR 
AU  - Flores-Fraile, María-Carmen
AU  - Padilla Fernández, Bárbara Yolanda
AU  - Valverde Martínez, Lauro Sebastián
AU  - Márquez Sánchez, Magaly Teresa
AU  - García Cenador, María Begoña
AU  - Lorenzo Gómez, María Fernanda
AU  - Flores Fraile, Javier
PY  - 2020
UR  - http://hdl.handle.net/10366/155363
AB  - [EN]Introduction: Prostate-specific antigen velocity (PSAV) is used to monitor men with clinical suspicion of prostate cancer (PCa), with a normal cut-off point of 0.3-0.5 ng/mL/year. The aim of the study is to establish the predictive capacity of...
LA  - eng
PB  - MDPI
KW  - PSA velocity
KW  - Free PSA
KW  - Total PSA ratio
KW  - Benign prostatic hyperplasia
KW  - Prostatitis
KW  - Prostate cancer
TI  - The association between prostate-specific antigen velocity (PSAV), value and acceleration, and of the free PSA/Total PSA index or ratio, with prostate conditions
DO  - 10.3390/JCM9113400
T2  - Journal of Clinical Medicine
VL  - 9
M2  - 1
ER  -